Brenntag Raises Guidance After Strong H1 as Working Capital Peaks
The German chemicals distributor upgraded its outlook following second-quarter results, citing market stabilization and disciplined inventory management despite elevated geopolitical tensions.
Brenntag Upgrades Outlook Amid Market Stabilization
Brenntag SE, the German chemicals distributor with a market capitalization around $10 billion, raised its full-year guidance following second-quarter results that management attributed to disciplined pricing and stable customer demand despite ongoing geopolitical tensions.
CEO Jens Birgersson told analysts that volume trends are "holding steady" with no significant uptick expected near-term. "We don't see an uptick and don't, at the moment, expect any big changes," he said, adding that "the Middle East crisis in one way, it has become normalized, but so has the oil price and so has the cost situation among our customers" (earnings call, 2026-08-12).
The company increased its guidance based on assumptions that current market conditions will persist, with Birgersson noting the company is "taking it month by month" given its lack of backlog.
Working Capital Surge Deemed Temporary
CFO Thomas Reisten addressed investor concerns about a €353 million working capital outflow in the second quarter, characterizing it as "a temporary technical effect" driven primarily by pricing rather than volume changes (earnings call, 2026-08-12).
"In such a strong growth situation, this increase is quite normal," Reisten explained, noting that total sales increased approximately 11% while inventory rose 11.8%, slightly below the average selling price increase. He confirmed the company has not experienced "significant product shortages" and has been "able to continue to safely deliver to our customers."
Crucially, Reisten indicated that "this temporary technical effect has reached at the end of the second quarter already its peak" and is expected to decline in the third quarter. Working capital turns improved to 7.5x, which management cited as evidence of efficient capital management.
Specialty Chemicals Show Selective Strength
Within the Specialties division, Material Science emerged as the top performer, with Birgersson attributing gains to both market dynamics and operational improvements. The company has shifted its commercial approach to focus "less strict" on competitive positioning and more on "gross profit" rather than gross profit per tonne.
Brenntag is also leveraging its Essentials division salesforce to target smaller specialty customers, an integration effort that Birgersson described as "self-help" rather than market-driven growth. The Life Science business showed progress across most segments, with Nutrition as an exception due to limited cost pressure on the sourcing side.
Personnel Costs Reflect Performance
Personnel expenses increased substantially year-over-year, primarily due to higher bonus provisions. Reisten disclosed that bonus provisions and related effects totaled approximately €40 million in the second quarter, reflecting the improved performance versus the prior year when "it became relatively clear that overall, we would be missing actually the guidance" (earnings call, 2026-08-12).
The company has reduced headcount by over 800 employees year-over-year and reached a run rate of €41 million in structural savings, predominantly from people-related costs. Management indicated salary increases for 2025 and early 2026 were "extremely tight" to align compensation with market levels after several years of above-market increases.
Birgersson noted that elevated shipping rates and oil prices are expected to persist, creating a higher baseline cost environment that generally favors Brenntag's business model in chemicals distribution.
This article was generated by MarginX from the earnings call on 2026-08-12. It is not investment advice.